SHH Equity Snapshot

688331 Weekly Equity Report

RemeGen Co., Ltd.

Latest Close 113.9 CNY 12 Jun 2026
1W Return 12.2% latest completed week
4W Return -0.7% short-term follow-through
12W Return -2.4% quarterly tape
Trend Breadth 98.1% 51 of 52 weeks active
Volume Ratio 1.1x vs 13-week average
Company Brief

What the company does

RemeGen Co., Ltd., a biopharmaceutical company, discovers, develops, produces, and commercializes biological drugs for the treatment of autoimmune, oncology, and ophthalmic diseases in Mainland China and the United States. The company offers Telitacicept (RC18) for the treatment of systemic lupus erythematosus (SLE) autoimmune disease, rheumatoid arthritis, and myasthenia gravis; and Disitamab Vedotin (RC48), an antibody drug conjugate for the treatment of gastric cancer, urothelial carcinoma, breast cancer, and other tumors. It also develops products in various stages, including RC-28E, a fusion protein that targets vascular endothelial growth factor (VEGF) and fibroblast growth factor (FGF); RC88, …

Snapshot

What the weekly tape is saying

688331 closed the latest completed week at 113.9 CNY. The 4-week return is -0.7% and the 12-week return is -2.4%. Trend Signal is active, Market Dynamics is -0.37. Setup signature: Balanced read with a 51/100 composite read.

Trend Signal Active
Market Dynamics No fresh buy
Price vs Trend 5.2%
Volume 1.1x
Setup Cockpit

A compressed read of the whole setup

The radar blends trend persistence, momentum, Market Dynamics, Relative Strength, volume confirmation, and risk control into one weekly cockpit.

Composite setup radar

Scoreboard

Trend 99 Persistence of active Trend Signal over the last year and current streak.
Momentum 46 Blend of 4-week and 12-week follow-through.
Dynamics 27 Latest Market Dynamics and whether pressure has improved over four weeks.
Relative Strength 89 Relative leadership and short-term RS change.
Volume 44 Participation compared with the 13-week volume baseline.
Risk Control 1 Drawdown and recent weekly volatility pressure.

16-week signal tape

27 Feb 6 Mar 13 Mar 20 Mar 27 Mar 3 Apr 10 Apr 17 Apr 24 Apr 1 May 8 May 15 May 22 May 29 May 5 Jun 12 Jun
Weekly return bar Trend Signal dot Positive Market Dynamics dot
Price Action

Price, Trend Line, and Fair Value

Weekly price context with the latest close, trend position, Fair Value gap, drawdown, and 52-week range location.

52-week price path

Price Trend Line Fair Value

Price map

Trend Line
108.3 CNY
Vs Trend Line
5.2%
Fair Value
63.52 CNY
Vs Fair Value
79.3%
52W High
156.8 CNY
52W Low
58.50 CNY
Drawdown
-27.4%
Range Position
56.4%
Momentum

Returns and trend persistence

Return windows separate the latest week from short-term and medium-term follow-through.

Return windows

1W 12.2%
4W -0.7%
12W -2.4%
26W 18.1%
52W 86.7%

Trend read

Active Streak
22 weeks
52W Active Weeks
51
52W Active Breadth
98.1%
Sector Scope
CN Healthcare
Sector Rank
9 of 486
Sector Percentile
98.4%
Peer Context

Sector and industry pulse

Peer breadth helps separate a stock-specific move from a broader group rotation.

Market Dynamics

Pressure, Relative Strength, and expectation

Market Dynamics and Relative Strength show whether buying pressure and relative leadership are confirming the price move.

Dynamics path

Market Dynamics Relative Strength

Signal state

Market Dynamics
-0.37
4W MD Change
-207.3%
Relative Strength
13.42
4W RS Change
-11.0%
Expectation
Undecided
Probability
47.31%
Volume

Participation and confirmation

Volume tells us whether the latest weekly move is being confirmed by unusual participation.

52-week volume profile

Volume map

Latest Volume
49.4M
13W Average
46.8M
52W Average
41.7M
Vs 13W
1.1x
Vs 52W
1.2x
Risk Anatomy

Volatility, downside weeks, and return shape

A compact risk profile shows whether the move is steady, volatile, or being driven by sharp one-week jumps.

26-week return distribution

Risk map

13W Volatility
9.6%
52W Volatility
9.8%
Upside Weeks
25
Downside Weeks
27
Downside Breadth
51.9%
Avg Gain / Loss
9.9% / -6.0%
Context

Classification, opportunities, risks, and watch points

Top-level read across company classification, constructive evidence, caution points, and the next things that matter.

Classification

Exchange
SHH
Country
CN
Sector
Healthcare
Industry
Biotechnology
Currency
CNY
Market Cap
61.4B

Opportunity signals

  • Trend Signal is active with a 22-week active streak.
  • Price is above the Trend Line, keeping the weekly tape constructive.
  • Price is above Fair Value, showing premium demand versus the model.
  • Latest weekly return ranks in the strongest part of its sector group.

Risk signals

  • Market Dynamics is negative, which weakens the current setup.
  • The share remains more than 20% below its 52-week high.

Watch next

  • Trend Line remains the key weekly regime level.
  • Market Dynamics is the pressure gauge to monitor for confirmation or fade.
  • A volume ratio above 1.5x would show stronger participation in the next move.
Weekly Tape

Recent completed weeks

The latest weekly rows behind the report snapshot.

Week Close Return Trend Fair Value MD RS Volume Signal
12 Jun 2026 113.9 CNY 12.2% 108.3 CNY 63.52 CNY -0.37 13.42 49.4M On
5 Jun 2026 101.5 CNY -12.5% 107.4 CNY 63.18 CNY -0.19 1.97 59.3M On
29 May 2026 116.0 CNY -0.6% 107.3 CNY 62.96 CNY -0.06 16.08 49.0M On
22 May 2026 116.7 CNY 1.8% 106.5 CNY 62.60 CNY 0.12 16.52 51.0M On
15 May 2026 114.7 CNY -7.5% 105.8 CNY 62.25 CNY 0.35 15.08 55.5M On
8 May 2026 123.9 CNY -4.2% 105.1 CNY 61.91 CNY 0.73 24.40 28.0M On
1 May 2026 129.3 CNY -2.8% 104.8 CNY 61.55 CNY 1.07 33.50 33.9M On
24 Apr 2026 133.0 CNY -11.4% 104.0 CNY 61.17 CNY 1.39 40.22 39.4M On
17 Apr 2026 150.1 CNY 10.8% 103.0 CNY 60.75 CNY 1.48 61.86 54.4M On
10 Apr 2026 135.5 CNY -9.1% 101.6 CNY 60.17 CNY 1.31 51.37 43.8M On
3 Apr 2026 149.1 CNY 20.7% 100.1 CNY 59.72 CNY 1.17 74.26 66.8M On
27 Mar 2026 123.6 CNY 5.9% 98.20 CNY 59.24 CNY 0.90 46.56 37.6M On
20 Mar 2026 116.7 CNY 4.2% 96.71 CNY 58.92 CNY 0.60 39.55 41.0M On
13 Mar 2026 112.0 CNY 5.8% 95.39 CNY 58.65 CNY 0.40 31.86 43.6M On